Catalyst Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CATALYST PHARMS, and what generic alternatives to CATALYST PHARMS drugs are available?
CATALYST PHARMS has three approved drugs.
There are eight US patents protecting CATALYST PHARMS drugs.
There are ninety-six patent family members on CATALYST PHARMS drugs in thirty-three countries and nineteen supplementary protection certificates in fifteen countries.
Summary for Catalyst Pharms
| International Patents: | 96 |
| US Patents: | 8 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Catalyst Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Catalyst Pharms | FYCOMPA | perampanel | TABLET;ORAL | 202834-001 | Oct 22, 2012 | RX | Yes | No | 6,949,571 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Catalyst Pharms | FIRDAPSE | amifampridine phosphate | TABLET;ORAL | 208078-001 | Nov 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Catalyst Pharms | FIRDAPSE | amifampridine phosphate | TABLET;ORAL | 208078-001 | Nov 28, 2018 | RX | Yes | Yes | 10,626,088 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Catalyst Pharms | FIRDAPSE | amifampridine phosphate | TABLET;ORAL | 208078-001 | Nov 28, 2018 | RX | Yes | Yes | 11,274,332 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for CATALYST PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg | ➤ Subscribe | 2016-10-24 |
International Patents for Catalyst Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0196308 | ⤷ Try a Trial |
| Serbia | 52752 | ⤷ Try a Trial |
| Hungary | 229553 | ⤷ Try a Trial |
| Brazil | 0111596 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Catalyst Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1300396 | 300566 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PERAMPANEL, EEN ZOUT OF EEN HYDRAAT DAARVAN; REGISTRATION NO/DATE: EU/1/12/776/001 .... 016 20120723 |
| 1300396 | SPC/GB12/057 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PERAMPANEL, OPTIONALLY IN THE FORM OF A SALT OR HYDRATE; REGISTERED: UK EU/1/12/776/001- 016 20120723 |
| 1764361 | C 2013 025 | Romania | ⤷ Try a Trial | PRODUCT NAME: PERAMPANEL3-(2-CIANOFENIL)-5-(2-PIRIDIL)-1-FENIL-1,2-DIHIDROPIRIDIN-2-ONA; NATIONAL AUBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/776/001 - EU/1/12/776/023; DATE OF FIRST AUTHORISATION IN EEA: 20120723 THORISATION NUMBER: EU/1/12/776/001 - EU/1/12/776/023; DATE OF NATIONAL AUTHORISATION: 20120723; NUM |
| 1764361 | PA2013017,C1764361 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PERAMPANELUM; REGISTRATION NO/DATE: EU/1/12/776/001 - EU/1/12/776/016, 2012 07 23 EU/1/12/776/017 - EU1/12/776/023 20121029 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
